190 related articles for article (PubMed ID: 15251934)
1. Quantification of circulating DNA in the plasma and serum of cancer patients.
Taback B; O'Day SJ; Hoon DS
Ann N Y Acad Sci; 2004 Jun; 1022():17-24. PubMed ID: 15251934
[TBL] [Abstract][Full Text] [Related]
2. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
Schwarzenbach H; Müller V; Stahmann N; Pantel K
Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.
Taback B; Fujiwara Y; Wang HJ; Foshag LJ; Morton DL; Hoon DS
Cancer Res; 2001 Aug; 61(15):5723-6. PubMed ID: 11479206
[TBL] [Abstract][Full Text] [Related]
4. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
Bremnes RM; Sirera R; Camps C
Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585
[TBL] [Abstract][Full Text] [Related]
6. Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy.
Gautschi O; Bigosch C; Huegli B; Jermann M; Marx A; Chassé E; Ratschiller D; Weder W; Joerger M; Betticher DC; Stahel RA; Ziegler A
J Clin Oncol; 2004 Oct; 22(20):4157-64. PubMed ID: 15483026
[TBL] [Abstract][Full Text] [Related]
7. Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer.
Board RE; Williams VS; Knight L; Shaw J; Greystoke A; Ranson M; Dive C; Blackhall FH; Hughes A
Ann N Y Acad Sci; 2008 Aug; 1137():98-107. PubMed ID: 18837931
[TBL] [Abstract][Full Text] [Related]
8. Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases.
Thijssen MA; Swinkels DW; Ruers TJ; de Kok JB
Anticancer Res; 2002; 22(1A):421-5. PubMed ID: 12017326
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of plasma DNA in colorectal cancer patients: a novel prognostic tool.
Frattini M; Gallino G; Signoroni S; Balestra D; Battaglia L; Sozzi G; Leo E; Pilotti S; Pierotti MA
Ann N Y Acad Sci; 2006 Sep; 1075():185-90. PubMed ID: 17108210
[TBL] [Abstract][Full Text] [Related]
10. Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer.
Schwarzenbach H; Stoehlmacher J; Pantel K; Goekkurt E
Ann N Y Acad Sci; 2008 Aug; 1137():190-6. PubMed ID: 18837946
[TBL] [Abstract][Full Text] [Related]
11. Detection of mitochondrial DNA alterations in plasma of malignant melanoma patients.
Takeuchi H; Fujimoto A; Hoon DS
Ann N Y Acad Sci; 2004 Jun; 1022():50-4. PubMed ID: 15251939
[TBL] [Abstract][Full Text] [Related]
12. Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays.
Sozzi G; Roz L; Conte D; Mariani L; Andriani F; Verderio P; Pastorino U
J Natl Cancer Inst; 2005 Dec; 97(24):1848-50. PubMed ID: 16368947
[TBL] [Abstract][Full Text] [Related]
13. Free circulating nucleic acids in plasma and serum (CNAPS) -- Useful for the detection of lung cancer patients?
Fleischhacker M; Schmidt B
Cancer Biomark; 2010; 6(3-4):211-9. PubMed ID: 20660966
[TBL] [Abstract][Full Text] [Related]
14. Prediction of breast tumor progression by integrity of free circulating DNA in serum.
Umetani N; Giuliano AE; Hiramatsu SH; Amersi F; Nakagawa T; Martino S; Hoon DS
J Clin Oncol; 2006 Sep; 24(26):4270-6. PubMed ID: 16963729
[TBL] [Abstract][Full Text] [Related]
15. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
[TBL] [Abstract][Full Text] [Related]
16. Optimizing the yield and utility of circulating cell-free DNA from plasma and serum.
Xue X; Teare MD; Holen I; Zhu YM; Woll PJ
Clin Chim Acta; 2009 Jun; 404(2):100-4. PubMed ID: 19281804
[TBL] [Abstract][Full Text] [Related]
17. Quantification of plasma cell-free DNA in patients with gastric cancer.
Sai S; Ichikawa D; Tomita H; Ikoma D; Tani N; Ikoma H; Kikuchi S; Fujiwara H; Ueda Y; Otsuji E
Anticancer Res; 2007; 27(4C):2747-51. PubMed ID: 17695442
[TBL] [Abstract][Full Text] [Related]
18. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors.
Zachariah RR; Schmid S; Buerki N; Radpour R; Holzgreve W; Zhong X
Obstet Gynecol; 2008 Oct; 112(4):843-50. PubMed ID: 18827127
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic potential of circulating nucleic acids for oncology.
Goessl C
Expert Rev Mol Diagn; 2003 Jul; 3(4):431-42. PubMed ID: 12877383
[TBL] [Abstract][Full Text] [Related]
20. Circulating mitochondrial nucleic acids have prognostic value for survival in patients with advanced prostate cancer.
Mehra N; Penning M; Maas J; van Daal N; Giles RH; Voest EE
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):421-6. PubMed ID: 17255261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
